Older Patents Get Help As Federal Circuit Sides With Novartis In Gilenya, Everolimus Disputes
December 10, 2018
By: Brenda Sandburg
Pink Sheet
Axinn counsel Thomas Hedemann was quoted in the Pink Sheet article, "Older Patents Get Help As Federal Circuit Sides With Novartis In Gilenya, Everolimus Disputes."
Click here to access the article. A subscription is required.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Informa Antitrust Texas 2025
Speaking Engagement
Antitrust
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
MCCA Gala 2025
Sponsorship
Antitrust
Centerforce IP Strategy Summit: Palo Alto
Speaking Engagement
Intellectual Property
Consero Healthcare General Counsel Forum 2025
Speaking Engagement
Antitrust
CCWC 21st Annual Career Strategies Conference
Speaking Engagement
Pro Bono Partnership 28th Anniversary Gala
Sponsorship
Antitrust
Ronald McDonald House New York Together in Gold Annual Gala
Sponsorship
Antitrust
Fordham 52nd Annual Conference on International Antitrust Law and Policy
Speaking Engagement
Antitrust
Kisaco Research Trade Secret Legal Protection Conference 2025
Speaking Engagement
Intellectual Property